Loading...
Beam Therapeutics Inc.
BEAM•NASDAQ
Healthcare
Biotechnology
$20.83
$-0.89(-4.10%)
Beam Therapeutics Inc. (BEAM) Financial Performance & Income Statement Overview
Review Beam Therapeutics Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-83.18%
↓ 83.18%
Operating Income Growth
-135.47%
↓ 135.47%
Net Income Growth
-184.28%
↓ 184.28%
Operating Cash Flow Growth
-132.75%
↓ 132.75%
Operating Margin
-677.47%
↓ 677.47%
Gross Margin
74.06%
↑ 74.06%
Net Profit Margin
-609.24%
↓ 609.24%
ROE
-44.24%
↓ 44.24%
ROIC
-32.50%
↓ 32.50%
Beam Therapeutics Inc. (BEAM) Income Statement & Financial Overview
Review Beam Therapeutics Inc.'s (BEAM) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $30.07M | $14.27M | $11.77M | $7.41M |
| Cost of Revenue | $5.44M | $5.47M | $5.58M | $5.43M |
| Gross Profit | $24.62M | $8.79M | $6.20M | $1.98M |
| Gross Profit Ratio | $0.82 | $0.62 | $0.53 | $0.27 |
| R&D Expenses | $101.44M | $94.26M | $87.04M | $84.82M |
| SG&A Expenses | $28.66M | $26.52M | $24.05M | $21.29M |
| Operating Expenses | $130.10M | $120.77M | $111.09M | $106.11M |
| Total Costs & Expenses | $130.10M | $120.77M | $116.67M | $111.54M |
| Interest Income | $10.93M | $12.13M | $0.00 | $11.85M |
| Interest Expense | $0.00 | $0.00 | $14.19M | $0.00 |
| Depreciation & Amortization | $15.11M | $5.47M | $5.58M | $5.43M |
| EBITDA | -$84.93M | -$101.03M | -$99.32M | -$98.70M |
| EBITDA Ratio | -$2.82 | -$7.08 | -$8.44 | -$13.32 |
| Operating Income | -$100.04M | -$106.50M | -$104.89M | -$104.13M |
| Operating Income Ratio | -$3.33 | -$7.46 | -$8.91 | -$14.05 |
| Other Income/Expenses (Net) | $9.68M | $9.84M | $13.88M | $5.46M |
| Income Before Tax | -$90.35M | -$96.67M | -$91.01M | -$98.67M |
| Income Before Tax Ratio | -$3.005 | -$6.77 | -$7.73 | -$13.32 |
| Income Tax Expense | $0.00 | $0.00 | $39000.00 | $5.39M |
| Net Income | -$90.35M | -$96.67M | -$91.05M | -$98.67M |
| Net Income Ratio | -$3.005 | -$6.77 | -$7.73 | -$13.32 |
| EPS | -$1.09 | -$1.17 | -$1.11 | -$1.21 |
| Diluted EPS | -$1.09 | -$1.17 | -$1.11 | -$1.21 |
| Weighted Avg Shares Outstanding | $82.82M | $82.41M | $82.31M | $81.70M |
| Weighted Avg Shares Outstanding (Diluted) | $82.82M | $82.41M | $82.31M | $81.70M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan